Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
MSF Access Campaign The new “gold standard” for treating cryptococcal meningitis approved by @WHO, remains inaccessible where burden is at its highest, and therefore needed most. Read the letter raising our concerns to @MylanNews 05:50 - 27 Jul 2018